List of works - Hiroyu Hatano

A Low T Regulatory Cell Response May Contribute to Both Viral Control and Generalized Immune Activation in HIV Controllers ⬇️

scientific article published on January 31, 2011

A Randomized Controlled Trial Assessing the Effects of Raltegravir Intensification on Endothelial Function in Treated HIV Infection ⬇️

scientific article published on November 1, 2012

A randomized, controlled trial of raltegravir intensification in antiretroviral-treated, HIV-infected patients with a suboptimal CD4+ T cell response

scientific article

Antiretroviral therapy initiated within 6 months of HIV infection is associated with lower T-cell activation and smaller HIV reservoir size

scientific article published on 12 July 2013

Cell-based measures of viral persistence are associated with immune activation and programmed cell death protein 1 (PD-1)-expressing CD4+ T cells

scientific article published on 22 October 2012

Evidence for persistent low-level viremia in individuals who control human immunodeficiency virus in the absence of antiretroviral therapy

scientific article published on 22 October 2008

Evidence of persistent low-level viremia in long-term HAART-suppressed, HIV-infected individuals

scientific article

Gut and blood differ in constitutive blocks to HIV transcription, suggesting tissue-specific differences in the mechanisms that govern HIV latency

article

HIV-Specific CD4+ T Cells May Contribute to Viral Persistence in HIV Controllers ⬇️

scientific article published on January 18, 2011

HIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortality

scientific article

Immunologic profiles distinguish aviremic HIV-infected adults

scientific article

Impact of HIV on CD8+ T cell CD57 expression is distinct from that of CMV and aging

scientific article

Longitudinal Genetic Characterization Reveals That Cell Proliferation Maintains a Persistent HIV Type 1 DNA Pool During Effective HIV Therapy

scientific article

Potential inflammatory consequences in HIV controllers

scientific article

Programmed death-1 expression on CD4⁺ and CD8⁺ T cells in treated and untreated HIV disease

scientific article

Prospective antiretroviral treatment of asymptomatic, HIV-1 infected controllers

scientific article

List of works by Hiroyu Hatano

A Low T Regulatory Cell Response May Contribute to Both Viral Control and Generalized Immune Activation in HIV Controllers ⬇️

A Randomized Controlled Trial Assessing the Effects of Raltegravir Intensification on Endothelial Function in Treated HIV Infection ⬇️

A randomized, controlled trial of raltegravir intensification in antiretroviral-treated, HIV-infected patients with a suboptimal CD4+ T cell response

Antiretroviral therapy initiated within 6 months of HIV infection is associated with lower T-cell activation and smaller HIV reservoir size

Cell-based measures of viral persistence are associated with immune activation and programmed cell death protein 1 (PD-1)-expressing CD4+ T cells

Evidence for persistent low-level viremia in individuals who control human immunodeficiency virus in the absence of antiretroviral therapy

Evidence of persistent low-level viremia in long-term HAART-suppressed, HIV-infected individuals

Gut and blood differ in constitutive blocks to HIV transcription, suggesting tissue-specific differences in the mechanisms that govern HIV latency

HIV-Specific CD4+ T Cells May Contribute to Viral Persistence in HIV Controllers ⬇️

HIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortality

Immunologic profiles distinguish aviremic HIV-infected adults

Impact of HIV on CD8+ T cell CD57 expression is distinct from that of CMV and aging

Longitudinal Genetic Characterization Reveals That Cell Proliferation Maintains a Persistent HIV Type 1 DNA Pool During Effective HIV Therapy

Potential inflammatory consequences in HIV controllers

Programmed death-1 expression on CD4⁺ and CD8⁺ T cells in treated and untreated HIV disease

Prospective antiretroviral treatment of asymptomatic, HIV-1 infected controllers